1,290 results on '"Mandorfer, Mattias"'
Search Results
2. Erwartungen der Generation Z an Lehr- und Prüfungsmethoden im österreichischen Medizinstudium
3. FXR-FGF19 signaling in the gut–liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defence
4. Reflex testing for anti-HDV in HBsAg-positive patients offers high diagnostic yield in a large Central European tertiary care center
5. Rapid improvement of hepatic steatosis and liver stiffness after metabolic/bariatric surgery: a prospective study
6. Management of varices but not anticoagulation is associated with improved outcome in patients with HCC and macrovascular tumour invasion
7. Clinical course of congestive hepatopathy pre/post heart transplantation
8. Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome
9. Diagnostic and prognostic performance of the LiverRisk score in tertiary care
10. Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD
11. Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies
12. Endoscopic band ligation is safe despite low platelet count and high INR
13. Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study
14. Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta
15. Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure
16. Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver disease
17. The systemic and hepatic alternative renin–angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammation
18. Bacterial translocation occurs early in cirrhosis and triggers a selective inflammatory response
19. Prevalence and dynamics of NAFLD-associated fibrosis in people living with HIV in Vienna from first presentation to last follow-up
20. Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV)
21. Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient
22. Inhibition of the renal apical sodium dependent bile acid transporter prevents cholemic nephropathy in mice with obstructive cholestasis
23. Alpha-1 Antitrypsin Augmentation and the Liver Phenotype of Adults With Alpha-1 Antitrypsin Deficiency (Genotype Pi∗ZZ)
24. Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome
25. Metabolomic profiles differentiate between porto-sinusoidal vascular disorder, cirrhosis, and health
26. Metabolic phenotyping of patients with advanced chronic liver disease for better characterization of cirrhosis regression
27. Lower free triiodothyronine (fT3) levels in cirrhosis are linked to systemic inflammation, higher risk of acute-on-chronic liver failure, and mortality
28. Platelet adhesion assessed by PFA-100 is not linked to progression of ACLD
29. Predicting survival in patients with ‘non-high-risk’ acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding
30. Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis
31. Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver Disease
32. Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis
33. Low mortality despite temporary liver dysfunction in severe courses of acute hepatitis E
34. Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder
35. The impact of COVID-19 on liver transplantation programs in Austria
36. Update zum Management der portalen Hypertonie nach Baveno VII – Was ist für die Praxis relevant?
37. Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in Cirrhosis
38. The impact of transmembrane 6 superfamily 2 (TM6SF2) rs58542926 on liver-related events in patients with advanced chronic liver disease
39. An impaired pituitary–adrenal signalling axis in stable cirrhosis is linked to worse prognosis
40. Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppression
41. Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis
42. Carvedilol Achieves Higher Hemodynamic Response and Lower Rebleeding Rates Than Propranolol in Secondary Prophylaxis
43. The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension
44. Inter- and intra-reader agreement for gadoxetic acid–enhanced MRI parameter readings in patients with chronic liver diseases
45. Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosis
46. Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease
47. Outcome of Budd-Chiari Syndrome Patients Treated With Direct Oral Anticoagulants: An Austrian Multicenter Study
48. Systematic review and meta-analysis: impact of anti-viral therapy on portal hypertensive complications in HBV patients with advanced chronic liver disease
49. Management of ACLD After HBV-Suppression and HCV-Cure
50. Lifestyle and Genetic Modifiers of Liver Disease Progression
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.